Investigations of gold(I) complexes as inhibitors of caspase-1

Srirajkumar Ranganathan1, Isabella D Reda1, Helen A Gustafson1

  • 1Department of Chemistry and Biochemistry, College of Science and Health, DePaul University, Chicago, IL 60614, USA.

PubMed

Insights

Gold(I) complexes effectively inhibit caspase-1, a key enzyme in inflammation. This discovery highlights their potential as anti-inflammatory drugs targeting cysteine-dependent proteins in diseases like gout and arthritis.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Immunology

Background:

  • Caspase-1 is a critical enzyme in the inflammasome, initiating inflammatory responses.
  • Inflammation mediated by caspase-1 is linked to diseases such as gout and rheumatoid arthritis.
  • Gold complexes are known for their anti-inflammatory potential.

Purpose of the Study:

  • To investigate the inhibitory effects of gold(I) complexes on caspase-1 activity.
  • To explore the potential of gold complexes as therapeutic agents for inflammatory diseases.

Main Methods:

  • Screening of various gold(I) molecular species for caspase-1 inhibition.
  • Determination of inhibition constants (KI) for effective compounds.

Main Results:

  • Several gold(I) complexes demonstrated significant inhibition of caspase-1.
  • The most potent inhibitors, PMe3AuCl and PPh3AuCl, exhibited KI values of 8 nM and 9 nM, respectively.
  • Inhibition occurred in the nanomolar range, indicating high efficacy.

Conclusions:

  • Gold(I) complexes are effective inhibitors of caspase-1.
  • The aurophilicity of sulfur in caspase-1's active site likely contributes to this inhibition.
  • Gold(I) complexes represent a promising class of drugs for targeting cysteine-dependent enzymes in inflammatory conditions.